Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
Not yet recruiting · NCT07448363 · Registry updated 2026-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Not stated | 2026-04-08 | NCT07448363 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Caja Costarricense de Seguro Social | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Caja Costarricense del Seguro Social | San José | Costa Rica | 6 |